drugset / Trial / NCT00026260
SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer
Treatment
Summary
RATIONALE: Biological therapy with drugs such as SU5416 may stop the growth of cervical cancer by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of SU5416 in treating patients who have persistent or recurrent cervical cancer.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- 2003-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | semaxanib | Small molecule | — | Intravenous |